Skip to main content

Peer Review reports

From: Cost-effectiveness of adding rituximab to splenectomy and romiplostim for treating steroid-resistant idiopathic thrombocytopenic purpura in adults

Original Submission
21 Feb 2014 Submitted Original manuscript
Author responded Author comments
Resubmission - Version 2
Submitted Manuscript version 2
Author responded Author comments
Reviewed Reviewer Report
Reviewed Reviewer Report
Reviewed Reviewer Report
Resubmission - Version 3
Submitted Manuscript version 3
Author responded Author comments
Reviewed Reviewer Report
Reviewed Reviewer Report
Reviewed Reviewer Report
Resubmission - Version 4
Submitted Manuscript version 4
Author responded Author comments
Reviewed Reviewer Report
Resubmission - Version 5
Submitted Manuscript version 5
Publishing
6 Jan 2015 Editorially accepted
22 Jan 2015 Article published 10.1186/s12913-015-0681-y

You can find further information about peer review here.

Back to article page